Bioanalytical Services Market Forecast Report, 2021-2031

Bioanalytical Services Market (Services: Immunochemistry Services, Quantitative Immunoassays, Cell-based Neutralization Assays, LCMS Method Development, Discovery Phase Bioanalysis, LCMS Sample Bioanalysis, GCP Bioanalysis Service, Biomarker Assays, Protein Analysis, and Others; Type: Small Molecule Bioanalysis, Large Molecule Bioanalysis, and Others; and End-user: Pharma & Biotechnology Companies, Contract Research Organizations, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Accelerating Bioanalytical Services to Reduce COVID-19 Impact

The bioanalytical services market is expected to witness abundance of growth opportunities in the upcoming years. The increasing number of infectious diseases is anticipated to revive the growth of the bioanalytical services market. Many pharmaceutical companies are now collaborating with research institutes to provide necessary bioanalyical services. Bioanalytical services involve pre-clinical tests, fluid or specimen testing, analysis of clinical samples, investigation of infection of viruses in the body, etc. In the global pandemic, these services have created significant growth opportunities for market contributors. Bioanalytical services played a major role in COVID-19 drug investigation and vaccination programs. Ongoing assays, vaccine testing solutions, drug inspection procedures, and technological advancement in pharmaceutical companies are creating revenue opportunities amid pandemic in the bioanalytical services market.

bioanalytical services market infographic

Request a sample to get extensive insights into the Bioanalytical Services Market

Overcoming Challenges in Bioanalytical Services Market

Dearth of highly skilled and productive manpower is one of the major challenges faced by many market contributors of the bioanaytical services market. Bioanalytical laboratories and research centers require skilled and experienced professionals to study and develop innovative solutions to fulfill the increasing demand of bioanalytical testing services from medical industry. In order to overcome this, governments are investing on providing training, webinars for students and graduate-level scientists to educate and keep themselves updated with the latest trends, and recent technological advancements. Moreover, to minimize the complexities in bioanalytics, acceptance and investment in new technologies, making use of better tools, and equipment for accurate sample analysis are required.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Emerging Contact Research Organizations (CRO) in Pharmaceuticals

The bioanalytical services market is projected to reach US$ 12.34 Bn by 2031. Manufacturers are bolstering their R&D capabilities to experiment with new technologies and applications. Escalating complexity and number of standards are driving the bioanalytical services market. Pharmaceutical companies are establishing their foot in outsourcing R&D activities to various contact research organizations to stay ahead of the competition and generate more revenue opportunities. Increasing government expenditure on healthcare, research & development activities, and trending advances in bioinformatics also strengthen the scope and expansion of CROs. Oncology is also a highly demanding branch of medicine that deals in diagnosis and treatment of cancer. The introduction of Big Data and artificial intelligence in medical field also elevate the demand in the bioanalytical services market.

Rising Prevalence of Infectious Diseases and Bioanalytical Services

Research & development activities have gained momentum in the field of drug development life cycles, pharmaceuticals, biopharmaceuticals, vaccinating procedures, and biosimilars since the coronavirus pandemic outbreak. The bioanalytical services have played an important role in the mitigation of the COVID-19 pandemic. Prevention and control of future waves of the various other infectious diseases such as SARS-CoV-2, HIV, etc. is extremely necessary these days, and thus, bioanalytical testing services are advantageous in many ways. There is an increasing demand for small molecular and large molecular bioanalytical services such as electrophoresis, tissue bioanalysis, immunochemistry services, electrochemical and titrimetric assays, immunoassays, etc. The high demand for these services are translating into lucrative revenue opportunities for manufacturers in the bioanalyttical services market.

Initiatives by Governments to Support R&D Activities

The bioanalytical services market is expected to advance at a CAGR of 8.2% during the forecast period. Pharmaceutical companies are increasing their output capacities in pre-clinical testing methods, drug safety, etc. with changing guidelines of international organizations. Thus, to understand the complex and changing standards in testing methods, clinical trials, and regulatory updates, governments are taking a step ahead to support manufacturers in the pharmaceutical companies, and investing in research and development activities. Bianalytical services are beneficial in early detection of coronavirus, and governments of various countries are supporting for the same. Increasing healthcare expenditure, outsourcing research activities by pharmaceutical companies in the bioanalytical services market help elevate the economy.

Rapid Growth & Development in North America Creating Profitable Revenue Opportunities

The increasing prevalence of infectious as well as chronic diseases such as diabetes all over the world demand for bioanalytical testing services. A large number of ongoing clinical trials, outsourcing services, research activities, and increasing investment by major pharmaceutical companies are some of the factors responsible for the growth of the bioanalytical services market in North America. The rapid increase in manufacturing of pharmaceuticals to fulfill consistently rising demand for healthcare services in the region is expected to propel the development of the bioanalytics services market in the region.

Manufacturers operating in the bioanalytical services market are shifting toward electronics medical devices to increase the performance of the services. Countries in the Asia Pacific market such as China, India, Japan, etc. are the fastest growing markets in providing and outsourcing bioanalytical services. Increasing investments on healthcare and highly efficient pharmaceutical outsourcing services are the two important factors that are boosting the market growth in Asia Pacific.

bioanalytical services market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Bioanalytical Services Market

Analysts’ Viewpoint

Experienced scientists are developing innovative methods to detect drug metabolites, drug analysis, and validation requirements by considering various regulatory and non-regulatory guidelines and standardizations. Drug samples can be analyzed by ensuring the quality, stability, and accuracy. Technological advancements in healthcare and pharmaceutical industries have the potential to create more revenue opportunities post COVID-19 period. Although there are some challenges in the bioanalytical services market that we need to overcome in the upcoming years such as lack of skilled professionals, methods to deal with highly complex, unstable drug compounds, etc. Hence, companies in the bioanalytical services market should experiment with new techniques to improvise the testing processes. In addition, elemental bioanalysis, biosimilar analysis, and validation methods are also contributing toward market expansion.

Bioanalytical Services Market: Overview

  • This report analyzes the current scenario and future prospects of the global bioanalytical services market. Increase in demand for bioanalytical testing services can be attributed to the rise in prevalence of infectious diseases, HIV, and other diseases. Additionally, surge in government initiatives to control outbreaks of infectious diseases such as coronavirus is projected to drive the global bioanalytical services market during the forecast period.
  • The report provides an elaborate executive summary, including a snapshot of various segments of the bioanalytical services market. It also provides elaborate information and data analysis of the global bioanalytical services market with regard to segments based on service, type, end-user, and region.
  • The overview section of the report provides a detailed qualitative analysis of drivers and restraints, and opportunities that affect the global bioanalytical services market
  • Additionally, the report includes company profiles, which provide information about their business, product portfolios, and competition landscape in the bioanalytical services market
  • The report on the global bioanalytical services market offers market attractiveness analysis of the regions and segments
  • The last section of the report comprises quantitative and qualitative analysis on market share/position of key players operating in the global bioanalytical services market. It analyzes the key competitive strategies adopted by the major industry players, thereby presenting a thorough understanding of the competitive scenario in the global bioanalytical services market.

Bioanalytical Services Market: Key Segments

  • In terms of service, the global bioanalytical services market has been classified into immunochemistry services, quantitative immunoassays, cell-based neutralization assays, LCMS method development, discovery phase bioanalysis, LCMS sample bioanalysis, GCP bioanalysis service, biomarker assays, protein analysis, and others. The immunochemistry service segment held major share of the global bioanalytical services market in 2020, and the trend is anticipated to continue during the forecast period.
  • Based on type, the global bioanalytical services market has been categorized into small molecule analysis, large molecule analysis, and others. The small molecule analysis segment accounted for majority of the market share in 2020.
  • Based on end-user, the global bioanalytical services market has been divided into pharma & biotechnology companies, contract research organization, and others
  • The market value and forecast for each of these segments have been provided from 2017 to 2031. The CAGRs of respective segments have also been provided from 2021 to 2031, considering 2017 to 2019 as the historical years and 2020 as base year.

Bioanalytical Services Market: Regional Outlook

  • The global bioanalytical services market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
  • The bioanalytical services market report provides value and forecast for each region and country/sub-region from 2017 to 2031. The compound annual growth rates (CAGRs) for each of these regions and countries have also been provided for the forecast period from 2021 to 2031. The bioanalytical services market study also covers the competitive scenario in these regions.

Companies Mentioned in Report

  • Key players in the global bioanalytical services market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the global bioanalytical services market report are
    • PPD, Inc.
    • ICON plc
    • Laboratory Corporation of America
    • Charles River Laboratories International, Inc.
    • Syneos Health
    • SGS SA Toxikon, Inc.
    • Intertek Group
    • Pace Analytical Services
    • Medpace
    • PRA HEALTH SCIENCES
    • WuXi AppTec
    • IQVIA
    • Eurofins Scientific

Bioanalytical Services Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 5.4 Bn

Market Forecast Value in 2031

USD$ 12.4 Bn

Growth Rate (CAGR)

8.2%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, supply chain analysis, and parent industry overview.

Format

Electronic (PDF) + Excel

Market Segmentation

  • Service
    • Immunochemistry Services
    • Quantitative Immunoassays
    • Cell-based Neutralization Assays
    • LCMS Method Development
    • Discovery Phase Bioanalysis
    • LCMS Sample Bioanalysis
    • GCP Bioanalysis Service
    • Biomarker Assays
    • Protein Analysis
    • Others
  • Type
    • Small Molecule Bioanalysis
    • Large Molecule Bioanalysis
    • Others
  • End-user
    • Pharma & Biotechnology Companies
    • Contract Research Organizations
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Japan
  • China
  • India
  • Australia
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Customization Scope

Available upon request

Pricing

Available upon request

Bioanalytical Services Market – Segmentation

Service
  • Immunochemistry Services
  • Quantitative Immunoassays
  • Cell-based Neutralization Assays
  • LCMS Method Development
  • Discovery Phase Bioanalysis
  • LCMS Sample Bioanalysis
  • GCP Bioanalysis Service
  • Biomarker Assays
  • Protein Analysis
  • Others
Type
  • Small Molecule Bioanalysis
  • Large Molecule Bioanalysis
  • Others
End-user
  • Pharma & Biotechnology Companies
  • Contract Research Organizations
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of bioanalytical services market?

Bioanalytical services market is projected to reach US$ 12.34 Bn by 2031

What is the anticipated CAGR of the bioanalytical services market in the forecast period?

Bioanalytical services market is projected to expand at a CAGR of 8.2% from 2021 to 2031

What are the key driving factors for the growth of the bioanalytical services market?

Bioanalytical services market is driven by rise in prevalence of infectious diseases, HIV, and other diseases.

Which is the rising prominent segment in the bioanalytical services market?

The small molecule bioanalysis segment dominated the global bioanalytical services market and the trend is likely to continue during the forecast period.

Who are the key players in the global bioanalytical services market?

Key Players in bioanalytical services market include PPD, Inc., ICON plc, Laboratory Corporation of America, Charles River Laboratories International, Inc., Syneos Health, SGS SA

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Bioanalytical Services Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Services Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Bioanalytical Services Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)

        5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

        5.3. Technological Advancements

    6. Global Bioanalytical Services Market Analysis and Forecast, by Service

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Services, 2017–2031

            6.3.1. Immunochemistry Service

            6.3.2. Quantitative Immunoassays

            6.3.3. Cell-Based Neutralization Assays

            6.3.4. LCMS Method Development

            6.3.5. Discovery Phase Bioanalysis

            6.3.6. LCMS Sample Bioanalysis

            6.3.7. GCP Bioanalysis Service

            6.3.8. Biomarker Assays

            6.3.9. Protein Analysis

            6.3.10. Others

        6.4. Market Attractiveness By Service

    7. Global Bioanalytical Services Market Analysis and Forecast, by Type

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Type, 2017–2031

            7.3.1. Small Molecule Bioanalysis

            7.3.2. Large Molecule Bioanalysis

            7.3.3. Others

        7.4. Market Attractiveness Analysis, by Type

    8. Global Bioanalytical Services Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Pharma & Biotechnology Companies

            8.3.2. Contract Research Organizations

            8.3.3. Others

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Bioanalytical Services Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Country/Region

    10. North America Bioanalytical Services Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Service, 2017–2031

            10.2.1. Immunochemistry Service

            10.2.2. Quantitative Immunoassays

            10.2.3. Cell-Based Neutralization Assays

            10.2.4. LCMS Method Development

            10.2.5. Discovery Phase Bioanalysis

            10.2.6. LCMS Sample Bioanalysis

            10.2.7. GCP Bioanalysis Service

            10.2.8. Biomarker Assays

            10.2.9. Protein Analysis

            10.2.10. Others

        10.3. Market Value Forecast, by Type, 2017–2031

            10.3.1. Small Molecule Bioanalysis

            10.3.2. Large Molecule Bioanalysis

            10.3.3. Others

        10.4. Market Value Forecast, by End-user, 2017–2031

            10.4.1. Pharma & Biotechnology Companies

            10.4.2. Contract Research Organizations

            10.4.3. Others

        10.5. Market Value Forecast, by Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Service

            10.6.2. By Type

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Bioanalytical Services Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Service, 2017–2031

            11.2.1. Immunochemistry Service

            11.2.2. Quantitative Immunoassays

            11.2.3. Cell-Based Neutralization Assays

            11.2.4. LCMS Method Development

            11.2.5. Discovery Phase Bioanalysis

            11.2.6. LCMS Sample Bioanalysis

            11.2.7. GCP Bioanalysis Service

            11.2.8. Biomarker Assays

            11.2.9. Protein Analysis

            11.2.10. Others

        11.3. Market Value Forecast, by Type, 2017–2031

            11.3.1. Small Molecule Bioanalysis

            11.3.2. Large Molecule Bioanalysis

            11.3.3. Others

        11.4. Market Value Forecast, by End-user, 2017–2031

            11.4.1. Pharma & Biotechnology Companies

            11.4.2. Contract Research Organizations

            11.4.3. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. U.K.

            11.5.2. Germany

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Service

            11.6.2. By Type

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Bioanalytical Services Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Service, 2017–2031

            12.2.1. Immunochemistry Service

            12.2.2. Quantitative Immunoassays

            12.2.3. Cell-Based Neutralization Assays

            12.2.4. LCMS Method Development

            12.2.5. Discovery Phase Bioanalysis

            12.2.6. LCMS Sample Bioanalysis

            12.2.7. GCP Bioanalysis Service

            12.2.8. Biomarker Assays

            12.2.9. Protein Analysis

            12.2.10. Others

        12.3. Market Value Forecast, by Type, 2017–2031

            12.3.1. Small Molecule Bioanalysis

            12.3.2. Large Molecule Bioanalysis

            12.3.3. Others

        12.4. Market Value Forecast, by End-user, 2017–2031

            12.4.1. Pharma & Biotechnology Companies

            12.4.2. Contract Research Organizations

            12.4.3. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. China

            12.5.2. India

            12.5.3. Japan

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Service

            12.6.2. By Type

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Bioanalytical Services Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Service, 2017–2031

            13.2.1. Immunochemistry Service

            13.2.2. Quantitative Immunoassays

            13.2.3. Cell-Based Neutralization Assays

            13.2.4. LCMS Method Development

            13.2.5. Discovery Phase Bioanalysis

            13.2.6. LCMS Sample Bioanalysis

            13.2.7. GCP Bioanalysis Service

            13.2.8. Biomarker Assays

            13.2.9. Protein Analysis

            13.2.10. Others

        13.3. Market Value Forecast, by Type, 2017–2031

            13.3.1. Small Molecule Bioanalysis

            13.3.2. Large Molecule Bioanalysis

            13.3.3. Others

        13.4. Market Value Forecast, by End-user, 2017–2031

            13.4.1. Pharma & Biotechnology Companies

            13.4.2. Contract Research Organizations

            13.4.3. Others

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Service

            13.6.2. By Type

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Bioanalytical Services Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Service, 2017–2031

            14.2.1. Immunochemistry Service

            14.2.2. Quantitative Immunoassays

            14.2.3. Cell-Based Neutralization Assays

            14.2.4. LCMS Method Development

            14.2.5. Discovery Phase Bioanalysis

            14.2.6. LCMS Sample Bioanalysis

            14.2.7. GCP Bioanalysis Service

            14.2.8. Biomarker Assays

            14.2.9. Protein Analysis

            14.2.10. Others

        14.3. Market Value Forecast, by Type, 2017–2031

            14.3.1. Small Molecule Bioanalysis

            14.3.2. Large Molecule Bioanalysis

            14.3.3. Others

        14.4. Market Value Forecast, by End-user, 2017–2031

            14.4.1. Pharma & Biotechnology Companies

            14.4.2. Contract Research Organizations

            14.4.3. Others

        14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Service

            14.6.2. By Type

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix

        15.2. Market Share Analysis, by Company, 2020

        15.3. Competitive Business Strategies

        15.4. Company Profiles

            15.4.1. PPD, Inc.

                15.4.1.1. Company Description

                15.4.1.2. Business Overview

                15.4.1.3. Financial Overview

                15.4.1.4. SWOT Analysis

            15.4.2. ICON plc

                15.4.2.1. Company Description

                15.4.2.2. Business Overview

                15.4.2.3. Financial Overview

                15.4.2.4. SWOT Analysis

            15.4.3. Laboratory Corporation of America

                15.4.3.1. Company Description

                15.4.3.2. Business Overview

                15.4.3.3. Financial Overview

                15.4.3.4. SWOT Analysis

            15.4.4. Charles River Laboratories International, Inc.

                15.4.4.1. Company Description

                15.4.4.2. Business Overview

                15.4.4.3. Financial Overview

                15.4.4.4. SWOT Analysis

            15.4.5. Syneos Health

                15.4.5.1. Company Description

                15.4.5.2. Business Overview

                15.4.5.3. Financial Overview

                15.4.5.4. SWOT Analysis

            15.4.6. SGS SA

                15.4.6.1. Company Description

                15.4.6.2. Business Overview

                15.4.6.3. SWOT Analysis

            15.4.7. Toxikon, Inc.

                15.4.7.1. Company Description

                15.4.7.2. Business Overview

                15.4.7.3. SWOT Analysis

            15.4.8. Intertek Group

                15.4.8.1. Company Description

                15.4.8.2. Business Overview

                15.4.8.3. Financial Overview

                15.4.8.4. SWOT Analysis

            15.4.9. Pace Analytical Services

                15.4.9.1. Company Description

                15.4.9.2. Business Overview

                15.4.9.3. SWOT Analysis

            15.4.10. Medpace

                15.4.10.1. Company Description

                15.4.10.2. Business Overview

                15.4.10.3. Financial Overview

                15.4.10.4. SWOT Analysis

            15.4.11. PRA HEALTH SCIENCES

                15.4.11.1. Company Description

                15.4.11.2. Business Overview

                15.4.11.3. Financial Overview

                15.4.11.4. SWOT Analysis

            15.4.12. WuXi AppTec

                15.4.12.1. Company Description

                15.4.12.2. Business Overview

                15.4.12.3. Financial Overview

                15.4.12.4. SWOT Analysis

            15.4.13. IQVIA

                15.4.13.1. Company Description

                15.4.13.2. Business Overview

                15.4.13.3. Financial Overview

                15.4.13.4. SWOT Analysis

            15.4.14. Eurofins Scientific

                15.4.14.1. Company Description

                15.4.14.2. Business Overview

                15.4.14.3. Financial Overview

                15.4.14.4. SWOT Analysis

    List of Tables

    Table 01: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

    Table 02: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 03: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Bioanalytical Services Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

    Table 07: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 08: North America Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Bioanalytical Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

    Table 11: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 12: Europe Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Asia Pacific Bioanalytical Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

    Table 15: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 16: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

    Table 19: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 20: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Service, 2017–2031

    Table 23: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 24: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Bioanalytical Services Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Bioanalytical Services Market Value Share, by Type, 2020

    Figure 03: Global Bioanalytical Services Market Value Share, by Region, 2020

    Figure 04: Global Bioanalytical Services Market Value Share, by Service, 2020

    Figure 05: Global Bioanalytical Services Market Value Share, by End-user, 2020

    Figure 06: Global Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

    Figure 07: Global Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

    Figure 08: Global Bioanalytical Services Market Revenue (US$ Mn), by Immunochemistry Services, 2017–2031

    Figure 09: Global Bioanalytical Services Market Revenue (US$ Mn), by Quantitative Immunoassays, 2017–2031

    Figure 10: Global Bioanalytical Services Market Revenue (US$ Mn), by Cell-Based Neutralization Assays, 2017–2031

    Figure 11: Global Bioanalytical Services Market Revenue (US$ Mn), by LCMS Method Development, 2017–2031

    Figure 12: Global Bioanalytical Services Market Revenue (US$ Mn), by Discovery Phase Bioanalysis, 2017–2031

    Figure 13: Global Bioanalytical Services Market Revenue (US$ Mn), by LCMS Sample Bioanalysis, 2017–2031

    Figure 14: Global Bioanalytical Services Market Revenue (US$ Mn), by GCP Bioanalysis Service, 2017–2031

    Figure 15: Global Bioanalytical Services Market Revenue (US$ Mn), by Biomarker Assays, 2017–2031

    Figure 16: Global Bioanalytical Services Market Revenue (US$ Mn), by Protein Analysis, 2017–2031

    Figure 17: Global Bioanalytical Services Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 18: Global Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

    Figure 19: Global Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

    Figure 20: Global Bioanalytical Services Market Revenue (US$ Mn), by Small Molecule Bioanalysis, 2017–2031

    Figure 21: Global Bioanalytical Services Market Revenue (US$ Mn), by Large Molecule Bioanalysis, 2017–2031

    Figure 22: Global Bioanalytical Services Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 23: Global Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 24: Global Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 25: Global Bioanalytical Services Market Value (US$ Mn), by Pharma & Biotechnology Companies, 2017–2031

    Figure 26: Global Bioanalytical Services Market Value (US$ Mn), by Contract Research Organizations, 2017–2031

    Figure 27: Global Bioanalytical Services Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 28: Global Bioanalytical Services Market Value Share Analysis, by Region, 2020 and 2031

    Figure 29: Global Bioanalytical Services Market Attractiveness Analysis, by Region, 2021–2031

    Figure 30: North America Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 31: North America Bioanalytical Services Market Value Share, by Country, 2020–2031

    Figure 32: North America Bioanalytical Services Market Attractiveness Analysis, by Country, 2021–2031

    Figure 33: North America Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

    Figure 34: North America Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

    Figure 35: North America Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

    Figure 36: North America Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

    Figure 37: North America Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 38: North America Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 39: Europe Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 40: Europe Bioanalytical Services Market Value Share (%), by Country/Sub-region, 2020 and 2031

    Figure 41: Europe Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 42: Europe Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

    Figure 43: Europe Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

    Figure 44: Europe Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

    Figure 45: Europe Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

    Figure 46: Europe Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 47: Europe Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 48: Asia Pacific Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 49: Asia Pacific Bioanalytical Services Market Value Share (%), by Country/Sub-region, 2020 and 2031

    Figure 50: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 51: Asia Pacific Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

    Figure 52: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

    Figure 53: Asia Pacific Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

    Figure 54: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

    Figure 55: Asia Pacific Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 56: Asia Pacific Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 57: Latin America Bioanalytical Services Market Value (US$ Mn) Forecast, 2017–2031

    Figure 58: Latin America Bioanalytical Services Market Value Share, by Country/Sub-region, 2020–2031

    Figure 59: Latin America Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 60: Latin America Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

    Figure 61: Latin America Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

    Figure 62: Latin America Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

    Figure 63: Latin America Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

    Figure 64: Latin America Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 65: Latin America Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 66: Middle East & Africa Bioanalytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 67: Middle East & Africa Bioanalytical Services Market Value Share, by Country/Sub-region, 2020–2031

    Figure 68: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 69: Middle East & Africa Bioanalytical Services Market Value Share Analysis, by Service, 2020 and 2031

    Figure 70: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by Service, 2021–2031

    Figure 71: Middle East & Africa Bioanalytical Services Market Value Share Analysis, by Type, 2020 and 2031

    Figure 72: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by Type, 2021–2031

    Figure 73: Middle East & Africa Bioanalytical Services Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 74: Middle East & Africa Bioanalytical Services Market Attractiveness Analysis, by End-user, 2021–2031

Copyright © Transparency Market Research, Inc. All Rights reserved